GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » Deferred Policy Acquisition Costs

Thor Medical ASA (OSTO:NANOO) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Thor Medical ASA (OSTO:NANOO) Business Description

Industry
Traded in Other Exchanges
Address
Kjelsasveien 168 B, Oslo, NOR, 0884
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.